4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059641
Director acquired 4,218,632 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion | +4,218,632 | 4,218,641 | D | ||
| Derivatives | |||||||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series A Preferred Stock | −4,500,000 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series B-1 Preferred Stock | −798,067 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series B-2 Preferred Stock | −644,786 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series C Preferred Stock | −14,604,833 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series D-1 Preferred Stock | −8,711,335 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series D-2 Preferred Stock | −1,539,643 | 0 | D | ||
| APPLE TREE PARTNERS II LP Director | 2014-09-22 | Conversion · Series D-3 Preferred Stock | −13,370,422 | 0 | D | ||
Loading xslF345X03/doc4.xml…